Cerulean Pharma Inc. (CERU) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 116 transactions totaling $46.6M, demonstrating a bullish sentiment with $46.6M in net insider flow. The most recent transaction on Apr 3, 2017 involved a transaction of 10,273 shares valued at $7.5K.
No significant insider buying has been recorded for CERU in the recent period.
No significant insider selling has been recorded for CERU in the recent period.
Based on recent SEC filings, insider sentiment for CERU is bullish with an Insider Alignment Score of 100/100 and a net flow of $46.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Cerulean Pharma Inc. (CERU) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading CERU stock, having executed 116 transactions in the past 90 days. The most active insider is Alan L. Crane (Executive), who has made 9 transactions totaling $10.3M.
Get notified when executives and directors at CERU file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 3, 2017 | A. Friedman Paul | Executive | Award | 10,273 | $0.73 | $7.5K | |
| Jan 3, 2017 | A. Arbuckle Stuart | Executive | Award | 7,467 | $0.77 | $5.7K | |
| Jan 3, 2017 | A. Friedman Paul | Executive | Award | 4,870 | $0.77 | $3.7K | |
| Jan 3, 2017 | Mckee William | Executive | Award | 1,948 | $0.77 | $1.5K | |
| Jan 3, 2017 | Ross Parkinson David | Executive | Award | 16,234 | $0.77 | $12.5K | |
| Jan 3, 2017 | H. Rastetter William | Executive | Award | 24,350 | $0.77 | $18.7K | |
| Jan 3, 2017 | R. Walt David | Executive | Award | 14,935 | $0.77 | $11.5K | |
| Dec 31, 2016 | T. Guiffre Christopherd | Executive | Award | 5,733 | $0.60 | $3.4K | |
| Oct 3, 2016 | A. Arbuckle Stuart | Executive | Award | 5,637 | $1.02 | $5.7K | |
| Oct 3, 2016 | A. Friedman Paul | Executive | Award | 3,676 | $1.02 | $3.7K | |
| Oct 3, 2016 | Mckee William | Executive | Award | 1,470 | $1.02 | $1.5K | |
| Oct 3, 2016 | Ross Parkinson David | Executive | Award | 12,254 | $1.02 | $12.5K | |
| Oct 3, 2016 | H. Rastetter William | Executive | Award | 18,382 | $1.02 | $18.7K | |
| Oct 3, 2016 | R. Walt David | Executive | Award | 11,274 | $1.02 | $11.5K | |
| Jun 30, 2016 | T. Guiffre Christopherd | Executive | Award | 3,999 | $1.80 | $7.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 47 | $46.6M | 99.5% |
Award(A) | 17 | $134.8K | 0.3% |
Exercise(M) | 1 | $100.2K | 0.2% |
Conversion(C) | 51 | $0 | 0.0% |
Insiders at Cerulean Pharma Inc. are accumulating shares at an accelerated pace. With 18 insiders making 116 transactions totaling $46.6M in purchases versus $0 in sales, the net buying activity of $46.6M signals strong executive confidence. Alan L. Crane (Executive) leads the buying activity with $10.3M in transactions across all time.